Published on January 13, 2021Citation: Mulé CM, Lavelle TA, Sliwinski SK, Wong JB. Shared Decision-Making During Initial Diagnostic and Treatment Planning Visits for Children with Autism Spectrum Disorder. Journal of Developmental & Behavioral Pediatrics 2021.Journal: Journal of Developmental and Behavioral PediatricsRead Publication
Published on December 2, 2020Citation: Neumann PJ, Chambers JD. "Eroding progress on evidence and outcomes: CMS’s new proposed pathway for medical device coverage," Health Affairs Blog, December 2, 2020.Journal: Health Affairs blogRead Publication
Published on December 2, 2020Citation: Basu A, Neumann PJ, Sullivan S. "International reference pricing: A lazy, misguided, bi-partisan plan to lower US drug prices," Health Affairs Blog, December 2, 2020.Journal: Health Affairs blogRead Publication
Published on November 19, 2020Citation: Neumann PJ, Cohen JT, Kim DD, Ollendorf DA. Consideration of value-based pricing for treatments and vaccines is important, even in the COVID-19 pandemic. Health Affairs 2020;40(1):53–61.Journal: Health AffairsRead Publication
Published on October 28, 2020Citation: Zuvekas SH, Grosse SD, Lavelle TA, Maenner MJ, Dietz P, Ji X. Healthcare Costs of Pediatric Autism Spectrum Disorder in the United States, 2003-2015. J Autism Dev Disord. 2021 Aug;51(8):2950-2958. doi: 10.1007/s10803-020-04704-z. Journal: Journal of Autism and Developmental DisordersRead Publication
Published on September 1, 2020Citation: Lerner D, Lavelle TA, Adler D, Chow W, Chang H, Godar SC, Rogers WH. A Population-Based Survey of the Workplace Costs for Caregivers of Persons With Treatment-Resistant Depression Compared With Other Health Conditions. J Occup Environ Med. 2020 Sep;62(9):746-756. doi: 10.1097/JOM.0000000000001957.Journal: Journal of Occupational and Environmental MedicineRead Publication
Published on August 18, 2020Citation: Lin, PJ, Cohen, JT, Neumann, PJ. Preparing the health‐care system to pay for new Alzheimer's drugs. Alzheimer's Dement. 2020; 1– 3.Journal: Alzheimer's & DementiaRead Publication
Published on July 27, 2020Citation: Ma S, Kim DD, Cohen JT, Neumann PJ. "Measuring “fearonomic effects” in valuing therapies: An application to COVID-19 in China," Value in Health (in press). Journal: Value in HealthRead Publication
Published on July 22, 2020Citation: Kim, DD, Silver, MC, Kunst, N, Cohen JT, Ollendorf DA, Neumann PJ. Perspective and costing in cost-effectiveness analysis, 1974–2018. PharmacoEconomics 38, 1135–1145 (2020).Journal: PharmacoEconomics Read Publication
Published on July 17, 2020Citation: Kim DD, Ollendorf DA, Neumann PJ, Fendrick M. "Crisis into opportunity: Can COVID-19 help set a path to improved health care efficiency?,"AJMC Commentary, June 17, 2020. Journal: American Journal of Managed CareRead Publication